The Patent Finder

Chimera Bioengineering, Inc.

Also on record
Records under this name other than the patents Chimera Bioengineering, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 16 patents it holds.

Showing 1 to 6 of 6 · Back to Chimera Bioengineering, Inc.

PatentTitleStatus Expires Confidence
US 11,459,572Gold Optimized CAR T-cells
Lapsed on the fee record
Ended Oct 4, 2026 · High confidence
Lapsed on the fee recordEnded Oct 4, 2026High confidence
US 11,311,577Coordinating gene expression using RNA destabilizing elements
Lapsed on the fee record
Ended Apr 26, 2026 · From the USPTO record
Lapsed on the fee recordEnded Apr 26, 2026From the USPTO record
US 9,777,064Smart CAR Devices, DE CAR Polypeptides, Side CARs and Uses Thereof
Lapsed on the fee record
Ended Oct 3, 2025 · High confidence
Lapsed on the fee recordEnded Oct 3, 2025High confidence
US 11,110,125Coordinating Gene Expression Using RNA Destabilizing Elements
Lapsed on the fee record
Ended Sep 7, 2025 · High confidence
Lapsed on the fee recordEnded Sep 7, 2025High confidence
US 11,085,917Methods for making novel antigen binding domains
Lapsed on the fee record
Ended Aug 10, 2025 · From the USPTO record
Lapsed on the fee recordEnded Aug 10, 2025From the USPTO record
US 11,052,111Smart CAR devices and DE CAR polypeptides for treating disease and methods for enhancing immune responses
Lapsed on the fee record
Ended Jul 6, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jul 6, 2025From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited